Ontobee: CMO

Clinical measurement ontology

4154 terms(s) returned

Term Type:

Record: 3101 to 3150 of 4154 Records

Page: 63 of 84, First Previous Next Last

Show Records Per Page

*A B C D E F G H I J K L M N O P Q R S T U V W 1 2 3 4 8

plasma uric acid level
plasma urotensin II level
plasma vasopressin level
plasma very low density lipoprotein cholesterol level
plasma very low density lipoprotein phospholipid level
platelet aggregation measurement
platelet count
platelet distribution width
platelet distribution width (percentage)
platelet function measurement
platelet intracellular calcium level
platelet measurement
platelet morphological measurement
platelet physiological measurement
platelet-large cell ratio
plateletcrit
pleura ribonucleic acid composition measurement
podocyte foot process height
podocyte foot process width
podocyte slit width
pons ribonucleic acid level
poorly differentiated malignant colorectal tumor number
poorly differentiated malignant colorectal tumor surface area measurement
post excision/regeneration liver volume to original liver volume ratio
post insult time to regain baseline tilted plane angle at loss of balance/traction
post-insult time of death
post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors
post-insult time of death due to metastatic liver tumors
post-insult time of death from IgM immunocytoma
post-insult time to mammary tumor formation
post-insult time to onset of T-cell lymphoma
post-insult time to onset of cerebrovascular lesion
post-insult time to onset of defensive burying response
post-insult time to onset of diabetes mellitus
post-insult time to onset of experimental arthritis
post-insult time to onset of experimental autoimmune encephalomyelitis
post-insult time to onset of experimental autoimmune neuritis
post-insult time to onset of experimental diabetes mellitus
post-insult time to onset of herpes simplex encephalitis
post-insult time to onset of leukemia
post-insult time to onset of moribundity
post-insult time to onset of type 1 diabetes mellitus
post-insult time to onset of type 2 diabetes mellitus
post-insult time to pituitary tumor formation
post-insult time to trigeminal nerve neurilemmoma formation
post-treatment survival time from doxorubicin-treated IgM immunocytoma
post-treatment survival time from drug-treated IgM immunocytoma
posterior cerebral artery inner diameter
potassium chloride response/sensitivity measurement
potassium chloride-induced blood vessel contractile force expressed as percent of force at baseline